CAMBRIDGE ONCOMETRIX
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The company develops a non-invasive risk stratification test for prostate cancer. The laboratory test will be capable of accurately selecting men for mpMRI-guided biopsy.
CAMBRIDGE ONCOMETRIX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2012-06-12
Address:
Haverhill, Suffolk, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cambridgeoncometrix.com
Total Employee:
1+
Status:
Active
Contact:
+441603 274 521
Email Addresses:
[email protected]
Total Funding:
1.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Mobile Non Scaleable Content GoDaddy LiteSpeed CPanel Wix DNS Krystal Hosting
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
i4i-connect
i4i-connect investment in Grant - Cambridge Oncometrix
SBRI Healthcare
SBRI Healthcare investment in Grant - Cambridge Oncometrix
Anglia Capital Group
Anglia Capital Group investment in Seed Round - Cambridge Oncometrix
SBRI Healthcare
SBRI Healthcare investment in Grant - Cambridge Oncometrix
MassChallenge
MassChallenge investment in Non Equity Assistance - Cambridge Oncometrix
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - Cambridge Oncometrix
Newest Events participated
Participated in Virgin Media Accelerator powered by Techstars Demo Day 2016
on 2016-07-07 as contestant
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
Official Site Inspections
http://www.cambridgeoncometrix.com
Unable to get host informations!!!
More informations about "Cambridge Oncometrix"
Cambridge Oncometrix Ltd.
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - condition that is likely to affect 1 in 8 men at some stage of their lives. Cambridge Oncometrix …See details»
Cambridge Oncometrix - Crunchbase Company Profile …
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The …See details»
Cambridge Oncometrix Ltd - camonx.org
Cambridge Oncometrix aims to improve the lives of men by enabling an early detection of prostate cancer. top of page. Home. Team. Contact. FAQ. MORE. History. 2012 . June – …See details»
cambridgeoncometrix.com
We would like to show you a description here but the site won’t allow us.See details»
CAMBRIDGE ONCOMETRIX LIMITED overview - Find and update …
Filing history for CAMBRIDGE ONCOMETRIX LIMITED (08101482) People for CAMBRIDGE ONCOMETRIX LIMITED (08101482) More for CAMBRIDGE ONCOMETRIX LIMITED …See details»
Cambridge Oncometrix 2025 Company Profile: …
Cambridge Oncometrix General Information Description. Developer of testing kits intended for early detection of prostate cancer. The company is developing a non-invasive risk stratification test capable of accurately selecting men for a …See details»
Cambridge Oncometrix Ltd - camonx.org
Cambridge Oncometrix aims to improve the lives of men by enabling an early detection of prostate cancer. top of page. Home. Team. Contact. FAQ. MORE. Contact information. …See details»
Cambridge Oncometrix | Company | RadialReport
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The company develops a non-invasive risk …See details»
Cambridge Oncometrix - Overview, News & Similar companies
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer. A condition that is likely to affect 1 in 8 men at some stage of their lives. Cambridge Oncometrix …See details»
Cambridge Oncometrix - Org Chart, Teams, Culture & Jobs - The …
View Cambridge Oncometrix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified …See details»
Cambridge Oncometrix Limited - LinkedIn
Cambridge Oncometrix Limited | 113 followers on LinkedIn. Non-invasive prostate cancer diagnostic test. | Prostate cancer can be cured in 99% of men if detected in time. Most men go to the doctor ...See details»
CAMBRIDGE ONCOMETRIX LIMITED - Dun & Bradstreet
Cambridge oncometrix limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united …See details»
Cambridge Oncometrix - Funding, Financials, Valuation & Investors
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Cambridge Oncometrix - Contacts, Employees, Board Members
Cambridge Oncometrix has 4 current employee profiles, including Director Irina Soltamova Solovyev. Cambridge Oncometrix has 2 board members and advisors, including Pavel …See details»
Cambridge Oncometrix - YouTube
Cambridge Oncometrix Co-founder and Director, Maxim Rossmann, tells us about his SBRI Healthcare funded innovation.See details»
MEDIA CENTRE | cambridgeoncometrix
The british association of urological surgeons. prostate conditions education council. prostate cancer ukSee details»
PARTNERS | cambridgeoncometrix
1st place. 2nd place. CollaborationsSee details»
Cambridge Oncometrix - Tech Stack, Apps, Patents & Trademarks
Organization. Cambridge Oncometrix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. About. …See details»
Non-invasive Molecular Test for those with Suspected Prostrate …
Oct 29, 2021 ONX is a non-invasive molecular test developed by UK based Cambridge Oncometrix. The test will enable risk-stratification and improve true positive rates within the …See details»
Cambridge Oncometrix Ltd - camonx.org
Is a novel test for prostate cancer based on biomarkers discovered by Cambridge Oncometrix. The test uses the fact that tumor cells cause changes in chemical composition of prostatic and …See details»